This proposal asked for funding to purchase tumor samples, cDNA and PCR reagents. The project is to investigate the role of the KEAP1-NRF2-SLC7A11 pathway in the resistance of malignant mesothelioma to chemotherapy. Dr. Huang received her B.S. in Medicine from Beijing Medical University, her M.S. in Medicine from the Institute of Virology, Chinese Academy of Preventive Medicine, and her Ph.D. in Molecular Genomics from the Ohio State University. She completed two postdoctoral trainings from the Ohio State University and Harvard Medical School.